Anixa Biosciences Company
Anixa Biosciences develops and acquires patented technologies for the purposes of patent monetization and patent assertion.
Funding Status:
IPO
Total Funding:
34265000
Last Funding Type:
Grant
Industry:
CAR-T
Estimated Revenue:
Less than $1M
Founded Date:
1982-01-01
Last Funding Date:
2021-05-26
Headquarters:
Melville, New York, United States
Investors Number:
1